Investors are betting big on former Paladin Labs CEO Jonathan Goodman and his latest pharmaceutical endeavour: Knight Therapeutics (TSXV:GUD). This … [Read more...] about Investors follow Paladin’s Goodman to Knight Therapeutics
Amaya Gaming (TSX:AYA) was the big winner at the fourth annual Cantech Letter Awards in Toronto Thursday night. After delivering the keynote at the … [Read more...] about Amaya Gaming wins big at Fourth Annual Cantech Letter Awards
Paladin Labs (TSX:PLB) is winning through the diversity of its offerings, says its interim CEO. This morning, Paladin reported its Q2, 2013 results. … [Read more...] about Paladin Labs CEO: here’s how we beat the street
Over the past several weeks, we have spent a lot of time looking back. 2012 was quietly the turnaround year we had hoped for in Canadian tech, the … [Read more...] about Canadian Tech Analysts Share their Top Picks for 2013
Paladin Labs (TSX:PLB) yesterday announced it has received approval from Health Canada for it grass pollen allergy treatment Oralair. According to … [Read more...] about Byron Capital’s Loe says Oralair Makes Paladin Less Risky, Reiterates Buy
Don Cherry and Ottawa Senators owner Eugene Melnyk teaming up? Not quite. While Don Cherry is still spokesman for Cold-FX, the most famous product of … [Read more...] about Valeant to acquire Afexa Life Sciences. A win, win, win situation?
For years now, soaring resource prices have meant that anyone pulling most anything out of the ground has done so profitably. Company's like Calgary … [Read more...] about Canada’s Seven Most Profitable Tech Stocks